AmyloiDia Sweden AB
Developing single-molecule sensitive blood tests for pre-symptomatic Alzheimer's diagnosis.
Overview
- 0
- Employees
- 100–149K SEK
- Revenue
- 2019
- Founded
Key Decision Makers
Dr Vladana Vukojević
CEO
Dr Sebastian Wärmländer
Member of the Steering Board
Dr Astrid Gräslund
Chair of the Steering Board
Dr Jüri Jarvet
Member of the Steering Board
+7 more contacts in Funnelfeedr
Description
AmyloiDia is an R&D-driven BioMedTech company dedicated to eradicating Alzheimer’s disease through early diagnosis. Their core mission involves translating advanced quantitative analytical methods into clinical healthcare applications. They have invented a novel, minimally invasive blood-based techn...